OpenEvidence logo

OpenEvidence

openevidence.com

Developer of an AI-powered information platform intended to organize medical knowledge and make it more useful, open, accessible, and understandable.

Most Valuable
LBX PPS
1Y return
$560
Implied Valuation
$13.3B
+10.9% premium
Last Round
Jan 2026
Series D
Series D · $12.0B
Activity
2.0
#84 most active

Price per share

12M · USD

Loading chart...

Funding history

$M raised · $B post-money

Loading chart...

Signals

4 latest

‘ChatGPT for Doctors’ Mulls New Financing at $20 Billion Valuation

OpenEvidence, the fast-growing startup that helps doctors find medical information through an AI chatbot, has considered raising $200 million after receiving offers from investors at a valuation of around $20 billion

Source: TheInformation

OpenEvidence Backs Study Showing Its AI Outperforms General LLMs on Clinical Evidence Quality

OpenEvidence has backed a study demonstrating that its platform outperforms general large language models on the quality of AI-generated clinical evidence, with coverage from both Fierce Healthcare and STAT highlighting the findings.

Source: Fierce Healthcare

OpenEvidence Partners with Pathway Labs to Integrate FDA-Cleared Multicondition Cardiology AI

OpenEvidence has announced a partnership with Pathway Labs to integrate its FDA-cleared AI for detecting multiple heart conditions into the OpenEvidence clinical workflow, marking a significant expansion into cardiology diagnostics.

Source: statnews.com

OpenEvidence Integrates ASCO Guidelines, Figures and Flowcharts into Specialty Oncology Model

OpenEvidence has integrated ASCO (American Society of Clinical Oncology) guidelines, figures, and flowcharts into its specialty oncology model, expanding its evidence-based clinical content for oncology use cases.

Source: News-Press NOW

LBXpro

Stay in the loop

Get private market insights and platform updates delivered to your inbox.

Office

Building A1, Dubai Digital Park, Dubai Silicon Oasis, Dubai, United Arab Emirates

Nothing on this site and the investment platform is intended as an offer to purchase or sell securities or a solicitation or recommendation of our securities transaction. Any financial information presented on the site and the investment platform are opinions, were prepared without taking into account your objectives, financial situation or needs. Investment results are not guarantees of future results.

Leo

AI analyst

Ask anything

Companies, valuations, IPO plans, market activity